David Mott - Director at Mersana Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
MRSN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Mott since 12/22/2023

Holdings reported by David Mott for Mersana Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 589K $1.6M $2.71 Jan 2, 2024 Direct
Common Stock 9.6K $26K $2.71 Jan 2, 2024 Indirect
Stock Option (right to buy) 55K Jun 11, 2024 Direct Common Stock

Transactions reported by David Mott for Mersana Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.